The University of British Columbia

$1,318,040.00 CAD

≈ 17 Canadians' average pay for a year

Department: National Research Council Canada
Program: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Recipient country: Canada
Fiscal year: 2019-2020
Agreement period: January 13, 2020 – December 31, 2023
Reference: nrc-cnrc:172-2021-2022-Q1-947806

Published purpose

This project will lead to an improved and more cost-effective AAV-LPL gene therapy for the treatment of Lipoprotein Lipase (LPL) Deficiency. The previous limitations of the high costs of production of advanced biologics, such as Glybera, will be addressed through new cost-effective manufacturing in Canada. This project will develop a further optimized AAV-based gene therapy for the treatment of LPL Deficiency as a pilot demonstration of a cost-effective production strategy for new advanced gene therapeutics in Canada.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful

View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions